Citation Impact
Citing Papers
Vitamin D Deficiency and Risk of Cardiovascular Disease
2008 Standout
Ginger—An Herbal Medicinal Product with Broad Anti-Inflammatory Actions
2005 Standout
Hypoxia-inducible factor 2α (HIF-2α) heterozygous-null mice exhibit exaggerated carotid body sensitivity to hypoxia, breathing instability, and hypertension
2011 StandoutNobel
In situ click chemistry generation of cyclooxygenase-2 inhibitors
2017 Standout
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
2004 Standout
Postnatal development and progression of renal dysplasia in cyclooxygenase-2 null mice
2000 StandoutNobel
1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system
2002 Standout
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Renal pathology resulting from PGHS-2 gene ablation in DBA/B6 mice
2002
Vitamin D: A millenium perspective
2003 Standout
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
The renin–angiotensin system in kidney development: role of COX‐2 and adrenal steroids
2004
Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): A review of recent research
2007 Standout
Cyclooxygenases in the skin: pharmacological and toxicological implications
2003
Sunlight and Vitamin D
2013 Standout
Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain
2007 Standout
Podocyte COX-2 Exacerbates Diabetic Nephropathy by Increasing Podocyte (Pro)renin Receptor Expression
2011
Up-regulation of glomerular COX-2 by angiotensin II: Role of reactive oxygen species
2005
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
2005 Standout
Cardiac hypertrophy in Aryl hydrocarbon receptor null mice is correlated with elevated angiotensin II, endothelin-1, and mean arterial blood pressure
2003
Organic Causes of Erectile Dysfunction in Men Under 40
2013 Standout
Basic biology and clinical application of specific cyclooxygenase-2 inhibitors
2000
Cyclo‐oxygenase‐2: pharmacology, physiology, biochemistry and relevance to NSAID therapy
1999
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes
2006 Standout
Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension1
2002
BiFeO3epitaxial thin films and devices: past, present and future
2014
Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
2005 Standout
A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats
2000
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Angiotensin II attenuates renal cortical cyclooxygenase-2 expression
1999
Cyclooxygenase-2 Inhibitors: A Painful Lesson
2006
TOCOX—A randomised, double‐blind, placebo‐controlled trial of rofecoxib (a COX‐2‐specific prostaglandin inhibitor) for the prevention of preterm delivery in women at high risk
2005
Pharmacological targeting of the HIF hydroxylases – A new field in medicine development
2016 StandoutNobel
Coxibs and Cardiovascular Disease
2004 Standout
Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
2000 Standout
Deficiency of COX-1 causes natriuresis and enhanced sensitivity to ACE inhibition
2001 StandoutNobel
The clinical potential of cyclooxygenase-2–specific inhibitors
1999
Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease
2004 Standout
A Role for Uric Acid in the Progression of Renal Disease
2002 Standout
Cyclooxygenase‐2 modulates cellular growth and promotes tumorigenesis
2003
Oxidative stress in chronic kidney disease
2018 Standout
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic Intervention
2003 Standout
Renal and cardiovascular effects of selective cyclooxygenase-2 inhibitors
2001
Renal Effects of COX-2-Selective Inhibitors
2001
The Coxibs, Selective Inhibitors of Cyclooxygenase-2
2001
Kidney function in mice lacking aldosterone
2005 StandoutNobel
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
2001 Standout
Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs
2003
Heme oxygenase and the cardiovascular–renal system
2005
Mechanisms of implantation: strategies for successful pregnancy
2012 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
TGF‐β signaling and the fibrotic response
2004 Standout
Angiotensin II feedback is a regulator of renocortical renin, COX-2, and nNOS expression
2002
Cyclooxygenases: Structural, Cellular, and Molecular Biology
2000 Standout
Regulation of cyclooxygenase-2 (COX-2) in rat renal cortex by adrenal glucocorticoids and mineralocorticoids
1999
Cyclosporine A Suppresses Cyclooxygenase-2 Expression in the Rat Kidney
2002
Signaling via the Angiotensin-Converting Enzyme Enhances the Expression of Cyclooxygenase-2 in Endothelial Cells
2004
Physiological regulation of cyclooxygenase-2 in the kidney
2001
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
2001 StandoutScience
1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system
2002
Antiferromagnetic spintronics
2018 Standout
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Mechanisms of Diabetic Complications
2013 Standout
Regular Nonsteroidal Anti-Inflammatory Drug Use and Erectile Dysfunction
2011
Angiotensin II stimulates cyclooxygenase-2 mRNA expression in renal tissue from rats with kidney failure
2002
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.
1998 Standout
Role of Renal Angiotensin II Type 1 Receptors in the Genesis of Hypertension
2007 StandoutNobel
Works of Junling Wang being referenced
Genetic deletion of COX-2 prevents increased renin expression in response to ACE inhibition
2001
Cyclooxygenase-2–selective inhibitors impair glomerulogenesis and renal cortical development
2000
Cyclooxygenase-2 in rat nephron development
1997
Constitutive expression of cyclooxygenase-2 in rat vas deferens
1998
Selective increase of cyclooxygenase-2 expression in a model of renal ablation
1998
Coexistence of ferroelectric triclinic phases in highly strained BiFeO3
2011